ABCD1 (P33897) variants and mutations
ABCD1 (also known as P33897) is a human protein-coding gene encoding an ATP-binding cassette sub-family D member 1 protein. An ATP-powered transporter that moves very-long-chain fatty-acyl molecules into peroxisomes for processing. It supports fatty-acid breakdown, myelin maintenance, and energy metabolism, and loss of ABCD1 function causes X-linked adrenoleukodystrophy. This analysis covers 1,619 ABCD1 variants and mutations. Of these, 82% have computational variant effect predictions. Disease context includes adrenoleukodystrophy, X-linked adrenoleukodystrophy, and hereditary disease. Example ABCD1 variants include M1V, P2T, and P2A.
Variant analysis overview
- Gene: ABCD1
- Protein: P33897
- UniProt accession: P33897
- Organism: Homo sapiens
- Variants analyzed: 1619
- Variant scope: all variants
- Completed: 2026-07-26
Variant and mutation evidence
- Variant composition: 1,118 unspecified-consequence records; 289 missense variants; 181 synonymous variants; 12 frameshift variants; 11 stop-gained variants; 1 in-frame insertions; 1 in-frame deletions; 6 substitution
- Prediction scores: 1,321 variants have prediction scores (82% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: adrenoleukodystrophy, X-linked adrenoleukodystrophy, hereditary disease, Spastic paraparesis, X-linked cerebral adrenoleukodystrophy, neurodegenerative disease, chronic primary adrenal insufficiency, X-linked spondyloepimetaphyseal dysplasia, adrenomyeloneuropathy, Hirschsprung disease, Ehlers-Danlos syndrome, kyphoscoliotic type 1, Ehlers-Danlos syndrome, musculocontractural type.
Protein structure and variant hotspots
- Protein features: 5 transmembrane segments; 2 domains; 1 binding sites; 2 post-translational modification sites.
- Structural context: 1,027 variants have structural context.
- PTM context: 3 variants overlap post-translational modification sites.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable ABCD1 variants
Examples include M1V, P2T, P2A, P2S, P2Q, P2L, P2P, V3M. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1V (p.Met1Val), rs2091702389, ClinGen CA415097154, ClinVar RCV001055844, MetaLR 0.69, MetaSVM 0.24, Pathogenic, Adrenoleukodystrophy
- P2T (p.Pro2Thr), gnomAD X-153725270-C-A, REVEL 0.20, CADD 15.60
- P2A (p.Pro2Ala), gnomAD X-153725270-C-G, REVEL 0.23, CADD 16.80
- P2S (p.Pro2Ser), gnomAD X-153725270-C-T, REVEL 0.14, CADD 16.90
- P2Q (p.Pro2Gln), gnomAD X-153725271-C-A, REVEL 0.22, CADD 19.30
- P2L (p.Pro2Leu), gnomAD X-153725271-C-T, REVEL 0.27, CADD 21.00
- P2P (p.Pro2Pro), rs2091702415, gnomAD X-153725272-G-T, CADD 13.50
- V3M (p.Val3Met), gnomAD X-153725273-G-A, REVEL 0.41, CADD 25.30
- V3L (p.Val3Leu), gnomAD X-153725273-G-T, REVEL 0.37, CADD 23.20
- V3V (p.Val3Val), gnomAD X-153725275-G-C, CADD 9.04
- L4I (p.Leu4Ile), gnomAD X-153725276-C-A, REVEL 0.28, CADD 22.90
- L4F (p.Leu4Phe), gnomAD X-153725276-C-T, REVEL 0.30, CADD 23.20
- L4L (p.Leu4Leu), rs2148388518, gnomAD X-153725278-C-T, CADD 5.62
- S5C (p.Ser5Cys), ExAC rs782061571, gnomAD rs782061571, REVEL 0.35, CADD 23.30
- S5P (p.Ser5Pro), gnomAD X-153725279-T-C, REVEL 0.47, CADD 22.50
- S5T (p.Ser5Thr), gnomAD X-153725279-T-A, REVEL 0.33, CADD 21.30
- S5Y (p.Ser5Tyr), gnomAD X-153725280-C-A, REVEL 0.39, CADD 23.10
- S5F (p.Ser5Phe), gnomAD X-153725280-C-T, REVEL 0.38, CADD 23.50
- S5S (p.Ser5Ser), gnomAD X-153725281-C-G, CADD 7.44
- R6S (p.Arg6Ser), NCI-TCGA TCGA novel, REVEL 0.25, CADD 0.17, Variant assessed as somatic; moderate impact.
- R6G (p.Arg6Gly), gnomAD X-153725282-A-G, REVEL 0.27, CADD 16.00
- R6M (p.Arg6Met), gnomAD X-153725283-G-T, REVEL 0.28, CADD 4.13
- R6R (p.Arg6Arg), gnomAD X-153725284-G-A, CADD 1.77
- P7H (p.Pro7His), gnomAD rs1557052136, REVEL 0.27, CADD 9.24
- P7S (p.Pro7Ser), rs1557052134, ClinGen CA415097241, ClinVar RCV003878043, gnomAD rs1557052134, REVEL 0.25, CADD 3.34, Likely benign, Adrenoleukodystrophy
- P7T (p.Pro7Thr), gnomAD X-153725285-C-A, REVEL 0.28, CADD 1.05
- P7A (p.Pro7Ala), gnomAD X-153725285-C-G, REVEL 0.23, CADD 0.32
- P7L (p.Pro7Leu), gnomAD X-153725286-C-T, REVEL 0.25, CADD 9.45
- P7P (p.Pro7Pro), gnomAD X-153725287-C-A, CADD 3.33
- R8W (p.Arg8Trp), rs2091702555, ClinGen CA415097251, ClinVar RCV002928009, ClinVar RCV003138398, REVEL 0.42, CADD 16.90, Uncertain significance, not provided; Inborn genetic diseases; Adrenoleukodystrophy
- R8G (p.Arg8Gly), rs2148388526, gnomAD X-153725284-GC-G, CADD 15.10
- R8R (p.Arg8Arg), rs2091702555, gnomAD X-153725288-C-A, CADD 5.27
- R8Q (p.Arg8Gln), gnomAD X-153725289-G-A, REVEL 0.25, CADD 13.20
- R8L (p.Arg8Leu), gnomAD X-153725289-G-T, REVEL 0.40, CADD 13.60
- P9S (p.Pro9Ser), gnomAD X-153725291-C-T, REVEL 0.29, CADD 0.14
- P9T (p.Pro9Thr), gnomAD X-153725291-C-A, REVEL 0.30, CADD 0.23
- P9H (p.Pro9His), gnomAD X-153725292-C-A, REVEL 0.23, CADD 8.57
- P9P (p.Pro9Pro), gnomAD X-153725293-C-A, CADD 6.20
- W10* (p.Trp10Ter), rs2148388538, ClinGen CA415097276, ClinVar RCV001576082, ClinVar RCV002570805, CADD 29.30, Pathogenic
- W10C (p.Trp10Cys), rs1304001811, TOPMed rs1304001811, gnomAD rs1304001811, ClinGen CA415097283, REVEL 0.28, CADD 4.09, Conflicting interpretations, Adrenoleukodystrophy; not specified; Inborn genetic diseases
- W10R (p.Trp10Arg), gnomAD X-153725294-T-C, REVEL 0.26, CADD 14.70
- W10L (p.Trp10Leu), gnomAD X-153725295-G-T, REVEL 0.27, CADD 7.29
- R11G (p.Arg11Gly), rs1224689084, ClinGen CA415097286, ClinVar RCV002266226, ClinVar RCV003096011, REVEL 0.57, CADD 12.20, Conflicting interpretations, Adrenoleukodystrophy; not specified
- R11P (p.Arg11Pro), rs782122122, ClinGen CA337233471, ClinVar RCV001483807, 1000Genomes rs782122122, REVEL 0.52, CADD 17.40, Conflicting interpretations, Adrenoleukodystrophy
- R11Q (p.Arg11Gln), 1000Genomes rs782122122, TOPMed rs782122122, gnomAD rs782122122, REVEL 0.35, CADD 15.90, Uncertain significance
- R11W (p.Arg11Trp), gnomAD X-153725297-C-T, REVEL 0.49, CADD 22.50
- R11R (p.Arg11Arg), gnomAD X-153725297-C-A, CADD 6.69
- R11L (p.Arg11Leu), gnomAD X-153725298-G-T, REVEL 0.52, CADD 16.10
- G12W (p.Gly12Trp), gnomAD X-153725300-G-T, REVEL 0.31, CADD 20.60
- G12R (p.Gly12Arg), gnomAD X-153725300-G-C, REVEL 0.28, CADD 12.70
- G12V (p.Gly12Val), gnomAD X-153725301-G-T, REVEL 0.26, CADD 4.68
- G12G (p.Gly12Gly), gnomAD X-153725302-G-T, CADD 4.87
- N13T (p.Asn13Thr), rs183021839, ClinGen CA10549898, ClinVar RCV000377597, ClinVar RCV001000486, REVEL 0.26, CADD 0.63, Benign/Likely benign, Inborn genetic diseases; not specified; Adrenoleukodystrophy
- N13H (p.Asn13His), gnomAD X-153725303-A-C, REVEL 0.14, CADD 12.90
- N13Y (p.Asn13Tyr), gnomAD X-153725303-A-T, REVEL 0.17, CADD 17.60
- N13D (p.Asn13Asp), gnomAD X-153725303-A-G, REVEL 0.13, CADD 12.70
- N13S (p.Asn13Ser), gnomAD X-153725304-A-G, REVEL 0.29, CADD 0.26
- N13K (p.Asn13Lys), gnomAD X-153725305-C-A, REVEL 0.27, CADD 8.78
- N13N (p.Asn13Asn), gnomAD X-153725305-C-T, CADD 7.17
- T14A (p.Thr14Ala), rs781900720, ClinGen CA10549899, ClinVar RCV000502342, ClinVar RCV000512675, REVEL 0.19, CADD 11.00, Conflicting interpretations, Inborn genetic diseases; not specified; not provided
- T14R (p.Thr14Arg), rs782161942, ClinGen CA10549900, ClinVar RCV000537259, ClinVar RCV001508971, REVEL 0.21, CADD 10.40, Conflicting interpretations, not provided; Adrenoleukodystrophy; Inborn genetic diseases
- T14K (p.Thr14Lys), gnomAD X-153725307-C-A, REVEL 0.28, CADD 11.20
- T14M (p.Thr14Met), gnomAD X-153725307-C-T, REVEL 0.25, CADD 17.10
- T14T (p.Thr14Thr), gnomAD X-153725308-G-T, CADD 5.57
- L15P (p.Leu15Pro), Ensembl rs2148388581, REVEL 0.55, CADD 21.50
- L15M (p.Leu15Met), gnomAD X-153725309-C-A, REVEL 0.27, CADD 17.30
- L15L (p.Leu15Leu), rs2148388577, gnomAD X-153725309-C-T, CADD 8.82
- L15Q (p.Leu15Gln), gnomAD X-153725310-T-A, REVEL 0.43, CADD 20.80
- K16N (p.Lys16Asn), TOPMed rs1378887547, gnomAD rs1378887547, REVEL 0.25, CADD 15.50
- K16K (p.Lys16Lys), gnomAD X-153725314-G-A, CADD 8.38
- R17C (p.Arg17Cys), gnomAD rs1557052156, REVEL 0.61, CADD 24.30
- R17H (p.Arg17His), rs782693577, ClinGen CA10549901, ClinVar RCV000707690, ClinVar RCV001001198, REVEL 0.48, CADD 24.10, Likely benign, not provided; Adrenoleukodystrophy; Inborn genetic diseases
- R17S (p.Arg17Ser), gnomAD X-153725315-C-A, REVEL 0.51, CADD 18.40
- R17L (p.Arg17Leu), gnomAD X-153725316-G-T, REVEL 0.56, CADD 21.20
- R17R (p.Arg17Arg), gnomAD X-153725317-C-T, CADD 9.74
- T18K (p.Thr18Lys), rs1557052159, ClinGen CA415097370, ClinVar RCV003513784, gnomAD rs1557052159, REVEL 0.52, CADD 10.10, Likely benign, Adrenoleukodystrophy
- T18M (p.Thr18Met), rs1557052159, ClinGen CA415097372, ClinVar RCV002273600, gnomAD rs1557052159, REVEL 0.42, CADD 15.50, Uncertain significance, not provided
- T18A (p.Thr18Ala), gnomAD X-153725318-A-G, REVEL 0.35, CADD 12.60
- T18P (p.Thr18Pro), gnomAD X-153725318-A-C, REVEL 0.62, CADD 16.40
- T18T (p.Thr18Thr), rs781855598, gnomAD X-153725320-G-A, CADD 3.05
- A19S (p.Ala19Ser), rs965462099, ClinGen CA337233489, ClinVar RCV001797965, ClinVar RCV002541315, REVEL 0.61, CADD 21.10, Conflicting interpretations, not specified; Adrenoleukodystrophy
- A19V (p.Ala19Val), TOPMed rs2091702943, REVEL 0.41, CADD 16.90
- A19T (p.Ala19Thr), gnomAD X-153725321-G-A, REVEL 0.49, CADD 17.80
- A19D (p.Ala19Asp), gnomAD X-153725322-C-A, REVEL 0.68, CADD 23.30
- A19A (p.Ala19Ala), rs1603231679, gnomAD X-153725323-C-T, CADD 0.43
- V20E (p.Val20Glu), rs782480731, ClinGen CA10549903, ClinVar RCV002643668, ExAC rs782480731, REVEL 0.48, CADD 22.40, Likely benign, Adrenoleukodystrophy
- V20M (p.Val20Met), gnomAD X-153725324-G-A, REVEL 0.26, CADD 18.30
- V20V (p.Val20Val), gnomAD X-153725326-G-T, CADD 7.34
- L21R (p.Leu21Arg), ExAC rs782611595, gnomAD rs782611595, REVEL 0.31, CADD 16.80
- L21I (p.Leu21Ile), gnomAD X-153725327-C-A, REVEL 0.16, CADD 6.88
- L21F (p.Leu21Phe), gnomAD X-153725327-C-T, REVEL 0.25, CADD 6.25
- L21P (p.Leu21Pro), gnomAD X-153725328-T-C, REVEL 0.31, CADD 17.60
- L21L (p.Leu21Leu), gnomAD X-153725329-C-A, CADD 6.22
- L22L (p.Leu22Leu), rs1184150367, gnomAD X-153725330-C-T, CADD 5.71
- L22P (p.Leu22Pro), gnomAD X-153725331-T-C, REVEL 0.72, CADD 23.80
- A23P (p.Ala23Pro), gnomAD X-153725331-TG-T, CADD 23.40
- A23S (p.Ala23Ser), gnomAD X-153725333-G-T, REVEL 0.37, CADD 22.00
- A23T (p.Ala23Thr), gnomAD X-153725333-G-A, REVEL 0.39, CADD 18.80
- A23V (p.Ala23Val), gnomAD X-153725334-C-T, REVEL 0.40, CADD 15.70
- A23D (p.Ala23Asp), gnomAD X-153725334-C-A, REVEL 0.72, CADD 23.30
- A23A (p.Ala23Ala), gnomAD X-153725335-C-A, CADD 5.13
- L24I (p.Leu24Ile), gnomAD X-153725336-C-A, REVEL 0.19, CADD 13.50
- L24F (p.Leu24Phe), gnomAD X-153725336-C-T, REVEL 0.34, CADD 16.10
- L24P (p.Leu24Pro), gnomAD X-153725337-T-C, REVEL 0.60, CADD 22.40
- L24L (p.Leu24Leu), gnomAD X-153725338-C-T, CADD 3.27
- A25V (p.Ala25Val), Ensembl rs2148388621, REVEL 0.27, CADD 10.20
- A25P (p.Ala25Pro), gnomAD X-153725339-G-C, REVEL 0.59, CADD 7.29
- A25S (p.Ala25Ser), gnomAD X-153725339-G-T, REVEL 0.21, CADD 4.17
- A25T (p.Ala25Thr), gnomAD X-153725339-G-A, REVEL 0.23, CADD 3.53
- A25G (p.Ala25Gly), gnomAD X-153725340-C-G, REVEL 0.28, CADD 19.00
- A25A (p.Ala25Ala), gnomAD X-153725341-G-A, CADD 3.96
- A26T (p.Ala26Thr), gnomAD X-153725342-G-A, REVEL 0.43, CADD 21.20
- A26S (p.Ala26Ser), gnomAD X-153725342-G-T, REVEL 0.51, CADD 22.60
- A26P (p.Ala26Pro), gnomAD X-153725342-G-C, REVEL 0.74, CADD 24.30
- A26V (p.Ala26Val), gnomAD X-153725343-C-T, REVEL 0.40, CADD 18.80
- A26G (p.Ala26Gly), gnomAD X-153725343-C-G, REVEL 0.52, CADD 22.70
- A26D (p.Ala26Asp), gnomAD X-153725343-C-A, REVEL 0.76, CADD 23.80
- A26A (p.Ala26Ala), gnomAD X-153725344-C-T, CADD 12.10
- Y27S (p.Tyr27Ser), rs1569540665, ClinGen CA415097462, ClinVar RCV000761212, Ensembl rs1569540665, AlphaMissense 0.41, MetaLR 0.64, Likely pathogenic, Adrenoleukodystrophy
- Y27H (p.Tyr27His), gnomAD X-153725345-T-C, REVEL 0.69, CADD 24.90
- Y27C (p.Tyr27Cys), gnomAD X-153725346-A-G, REVEL 0.73, CADD 25.50
- Y27F (p.Tyr27Phe), gnomAD X-153725346-A-T, REVEL 0.60, CADD 24.20
- G28R (p.Gly28Arg), gnomAD X-153725348-G-A, REVEL 0.77, CADD 24.80
- G28V (p.Gly28Val), gnomAD X-153725349-G-T, REVEL 0.72, CADD 23.20
- G28E (p.Gly28Glu), gnomAD X-153725349-G-A, REVEL 0.77, CADD 24.40
- G28G (p.Gly28Gly), gnomAD X-153725350-A-T, CADD 11.10
- A29D (p.Ala29Asp), rs2522263090, ClinGen CA415097488, ClinVar RCV002982398, ClinVar RCV003138423, REVEL 0.56, CADD 13.50, Uncertain significance, not provided; Adrenoleukodystrophy
- A29P (p.Ala29Pro), rs2522263080, ClinGen CA415097484, ClinVar RCV003625803, Uncertain significance, Adrenoleukodystrophy
- A29S (p.Ala29Ser), NCI-TCGA TCGA novel, REVEL 0.27, CADD 21.70, Variant assessed as somatic; moderate impact.
- A29T (p.Ala29Thr), gnomAD X-153725351-G-A, REVEL 0.23, CADD 19.00
- A29V (p.Ala29Val), gnomAD X-153725352-C-T, REVEL 0.30, CADD 1.53
- A29A (p.Ala29Ala), gnomAD X-153725353-C-A, CADD 10.10
- H30D (p.His30Asp), rs2522263111, ClinGen CA415097492, ClinVar RCV003139502, ClinVar RCV005616609, Uncertain significance, not provided
- H30Y (p.His30Tyr), gnomAD X-153725354-C-T, REVEL 0.36, CADD 19.70
- H30N (p.His30Asn), gnomAD X-153725354-C-A, REVEL 0.25, CADD 19.60
- H30R (p.His30Arg), gnomAD X-153725355-A-G, REVEL 0.51, CADD 14.30
- H30H (p.His30His), rs782195097, gnomAD X-153725356-C-T, CADD 9.06
- K31R (p.Lys31Arg), rs782454198, ClinGen CA10549906, ClinVar RCV002922346, ExAC rs782454198, REVEL 0.33, CADD 14.60, Conflicting interpretations, Adrenoleukodystrophy
- K31E (p.Lys31Glu), gnomAD X-153725357-A-G, REVEL 0.41, CADD 17.40
- K31K (p.Lys31Lys), rs2148388633, gnomAD X-153725359-A-G, CADD 10.10
- V32A (p.Val32Ala), gnomAD rs1557052179, REVEL 0.25, CADD 20.60
- V32F (p.Val32Phe), TOPMed rs2091703207, REVEL 0.35, CADD 5.94
- V32V (p.Val32Val), rs1557052182, gnomAD X-153725362-C-A, CADD 8.46
- Y33* (p.Tyr33Ter), rs2522263168, ClinGen CA415097542, ClinVar RCV003513705, CADD 34.00, Pathogenic
- Y33C (p.Tyr33Cys), gnomAD X-153725364-A-G, REVEL 0.57, CADD 22.90
- Y33Y (p.Tyr33Tyr), gnomAD X-153725365-C-T, CADD 8.39
- P34S (p.Pro34Ser), rs375019683, ClinGen CA10549907, ClinVar RCV000418353, ClinVar RCV001276529, REVEL 0.64, CADD 23.40, Conflicting interpretations, not provided; Adrenoleukodystrophy
- P34T (p.Pro34Thr), gnomAD X-153725366-C-A, REVEL 0.75, CADD 23.40
- P34L (p.Pro34Leu), gnomAD X-153725367-C-T, REVEL 0.68, CADD 22.60
- P34H (p.Pro34His), gnomAD X-153725367-C-A, REVEL 0.70, CADD 23.90
- P34P (p.Pro34Pro), gnomAD X-153725368-C-A, CADD 1.37
- L35L (p.Leu35Leu), gnomAD X-153725369-T-C, CADD 7.99
- L35F (p.Leu35Phe), gnomAD X-153725371-G-T, REVEL 0.41, CADD 15.60
- V36A (p.Val36Ala), rs2522263207, ClinGen CA415097577, ClinVar RCV002655040, Uncertain significance, Adrenoleukodystrophy
- V36M (p.Val36Met), gnomAD X-153725372-G-A, REVEL 0.35, CADD 20.10
- V36L (p.Val36Leu), gnomAD X-153725372-G-T, REVEL 0.26, CADD 14.10
- V36G (p.Val36Gly), gnomAD X-153725373-T-G, REVEL 0.46, CADD 22.40
- V36V (p.Val36Val), gnomAD X-153725374-G-T, CADD 8.46
- R37C (p.Arg37Cys), rs1479670923, ClinGen CA415097586, ClinVar RCV003310148, ClinVar RCV003624511, REVEL 0.47, CADD 21.20, Conflicting interpretations, Inborn genetic diseases; Adrenoleukodystrophy
- R37H (p.Arg37His), rs1257848735, TOPMed rs1257848735, gnomAD rs1257848735, REVEL 0.36, AlphaMissense 0.11, Uncertain significance
- R37L (p.Arg37Leu), rs1257848735, ClinGen CA415097591, ClinVar RCV000585313, ClinVar RCV006612416, REVEL 0.28, AlphaMissense 0.11, Uncertain significance, not provided; Adrenoleukodystrophy
- R37P (p.Arg37Pro), rs1257848735, ClinGen CA415097589, ClinVar RCV003489510, TOPMed rs1257848735, AlphaMissense 0.11, MetaLR 0.53, Uncertain significance, not provided
- R37G (p.Arg37Gly), gnomAD X-153725375-C-G, REVEL 0.50, CADD 18.20
- R37S (p.Arg37Ser), gnomAD X-153725375-C-A, REVEL 0.42, CADD 16.40
- R37R (p.Arg37Arg), gnomAD X-153725377-C-A, CADD 5.73
- Q38K (p.Gln38Lys), gnomAD X-153725378-C-A, REVEL 0.31, CADD 8.70
- Q38R (p.Gln38Arg), gnomAD X-153725379-A-G, REVEL 0.29, CADD 13.00
- Q38H (p.Gln38His), gnomAD X-153725380-G-T, REVEL 0.26, CADD 9.47
- C39Y (p.Cys39Tyr), TOPMed rs1204792059, REVEL 0.20, CADD 11.80
- C39R (p.Cys39Arg), gnomAD X-153725381-T-C, REVEL 0.23, CADD 17.30
- C39F (p.Cys39Phe), gnomAD X-153725382-G-T, REVEL 0.28, CADD 14.00
- C39S (p.Cys39Ser), gnomAD X-153725382-G-C, REVEL 0.23, CADD 13.90
- C39C (p.Cys39Cys), rs1557052192, gnomAD X-153725383-C-T, CADD 9.16
- C39* (p.Cys39Ter), gnomAD X-153725383-C-A, CADD 32.00
- L40V (p.Leu40Val), gnomAD X-153725384-C-G, REVEL 0.25, CADD 12.40
- L40L (p.Leu40Leu), gnomAD X-153725384-C-T, CADD 8.83
- L40M (p.Leu40Met), gnomAD X-153725384-C-A, REVEL 0.28, CADD 18.80
- L40P (p.Leu40Pro), gnomAD X-153725385-T-C, REVEL 0.44, CADD 18.30
- L40R (p.Leu40Arg), gnomAD X-153725385-T-G, REVEL 0.45, CADD 17.70
- L40Q (p.Leu40Gln), gnomAD X-153725385-T-A, REVEL 0.31, CADD 16.80
Public ABCD1 analysis runs
- ABCD1 analysis run — ABCD1 (1,619 variants) — completed 2026-07-26